10-Q: Horizon Space Acquisition II Corp. Reports Net Income for Q1 2025, Announces Business Combination Agreement

Horizon Space Acquisition II Corp. reports a net income of $472,592 for the quarter ended March 31, 2025, and announces a business combination agreement with SL Bio Ltd.

Summary

• Horizon Space Acquisition II Corp., a blank check company, reported its financial results for the quarter ended March 31, 2025.
• The company achieved a net income of $472,592, primarily driven by interest and dividend income from investments held in trust.
• Formation and operating costs for the quarter amounted to $253,479.
• As of March 31, 2025, the company had cash of $364,776 and working capital of $197,396.
• The company's initial public offering (IPO) was consummated on November 18, 2024, generating gross proceeds of $60,000,000.
• The underwriter's over-allotment option was exercised in full on November 21, 2024, resulting in additional gross proceeds of $9,000,000.
• Simultaneously with the IPO, a private placement generated total proceeds of $2,135,000.
• On May 9, 2025, the company entered into a business combination agreement with SL Bio Ltd.
• The company's management has determined that conditions raise substantial doubt about the company's ability to continue as a going concern.
• The company needs to complete a Business Combination within the Combination Period by November 18, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company reports net income, it also expresses concerns about its ability to continue as a going concern and the need for additional financing. The announcement of a business combination is a positive development, but the overall outlook is uncertain.

Positives

• The company generated net income of $472,592 for the quarter ended March 31, 2025.
• The company successfully completed its IPO and private placement, raising significant capital.
• The company has entered into a business combination agreement with SL Bio Ltd.

Negatives

• The company's management has determined that conditions raise substantial doubt about the company's ability to continue as a going concern.
• The company has incurred significant formation and operating costs.
• The company needs to complete a Business Combination within the Combination Period by November 18, 2025.

Risks

• The company's ability to consummate a Business Combination may be materially and adversely affected by ongoing global conflicts.
• The company's ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events.
• There is no assurance that the company's plans to raise capital or to complete its initial business combination will be successful.
• If the Company is unable to complete a Business Combination within the Combination Period by November 18, 2025, unless further extended, the Company's board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company.

Future Outlook

The company intends to use substantially all of the net proceeds of the IPO, including the funds held in the Trust Account, to acquire a target business or businesses and to pay its expenses relating thereto.

Management Comments

• Management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern.
• Management's plan in addressing this uncertainty is through the working capital loans from our Sponsor or its affiliates.

Industry Context

This announcement is typical for a SPAC in its search phase, highlighting financial status and progress towards finding a suitable merger target. The focus on a business combination agreement indicates advancement in the SPAC's lifecycle.

Comparison to Industry Standards

• SPACs typically have a limited operating history and rely on the IPO proceeds to fund their search for a target company.
• The net income generated from interest on the trust account is a common characteristic of SPACs during the pre-combination phase.
• The announcement of a business combination agreement is a significant milestone for a SPAC, indicating progress towards completing its objective.
• Comparable companies include other SPACs listed on NASDAQ, such as those in the healthcare or technology sectors, which are common targets for SPAC mergers.

Related Party Transactions

• The Sponsor purchased private placement units at $10.00 per unit.
• The Sponsor may provide working capital loans to the company.
• The company will pay an affiliate of the Sponsor $10,000 per month for administrative support services.

Stakeholder Impact

• Shareholders will be impacted by the business combination with SL Bio Ltd.
• Shareholders may have the opportunity to redeem their shares.
• The company's ability to complete a business combination will impact the value of its securities.

Next Steps

• The company will seek shareholder approval for the business combination with SL Bio Ltd.
• The company will work towards consummating the business combination agreement.
• The company will need to secure additional financing if required to complete the business combination or fund operations.

Key Dates

Keywords

business combination, SPAC, IPO, Horizon Space Acquisition II Corp, SL Bio Ltd, financial results, blank check company